Bulletin
Investor Alert

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210293917/composite

$

68.83

Change

+0.06 +0.09%

Volume

Volume 421,088

Jun 11, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210293917/composite

Previous close

$ 69.29

$ 68.77

Change

-0.52 -0.75%

Day low

Day high

$68.65

$69.25

Open
Open: 69.14

52 week low

52 week high

$56.56

$78.94

Open

Market cap

$86.90B

Average volume

7.05M

P/E ratio

303.09

Rev. per Employee

$1.81M

EPS

0.23

Dividend

0.71

Div yield

4.13%

Ex dividend date

6/14/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gild

MarketWatch News on GILD

  1. Run a Quality Check to Limit Chances of a Dividend Stock Shock

    10:30 a.m. May 27, 2021

    - Lawrence C. Strauss

  2. Run a Quality Check to Limit Chances of a Dividend Stock Shock

    10:30 a.m. May 27, 2021

    - Lawrence C. Strauss

  3. Regeneron Earnings Lift Stock. Here's Why.

    7:34 a.m. May 6, 2021

    - Josh Nathan-Kazis

  4. Pfizer Expects $26B in Covid-19 Vaccine Sales This Year

    10:24 a.m. May 4, 2021

    - Josh Nathan-Kazis

  5. Moderna to Sell Up to 500 Million Covid Vaccine Doses to COVAX

    9:58 a.m. May 3, 2021

    - Josh Nathan-Kazis

  6. What Ails Gilead's Sales

    6:59 p.m. April 29, 2021

    - Bill Alpert

  7. Gilead stock falls as COVID-19 drug sales dwindle

    4:27 p.m. April 29, 2021

    - Jeremy C. Owens

  8. Gilead stock falls as COVID-19 drug sales dwindle

    4:26 p.m. April 29, 2021

    - Jeremy C. Owens

  9. Merck and Gilead Sciences Sign Deals to Aid India's Covid-19 Fight

    11:34 a.m. April 27, 2021

    - Josh Nathan-Kazis

  10. Gilead to donate 450,000 doses of COVID-19 drug to India

    7:14 a.m. April 27, 2021

    - Jaimy Lee

  11. Buy Moderna Stock. It’s More Than a One-Hit Wonder.

    6:55 a.m. April 26, 2021

    - Josh Nathan-Kazis

  12. Buy Moderna Stock. It’s More Than a One-Hit Wonder.

    1:03 p.m. April 23, 2021

    - Josh Nathan-Kazis

  13. FDA Grants Full Approval to Gilead Breast Cancer Drug

    8:14 a.m. April 8, 2021

    - Josh Nathan-Kazis

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gild

Other News on GILD

  1. What's Behind This Wild-Card Coronavirus Stock?

    6:15 a.m. June 8, 2021

    - Motley Fool

  2. 7 Best Stocks To Buy To Hedge Against A Potential Downturn

    3:18 p.m. June 1, 2021

    - InvestorPlace.com

  3. Could Nano-X Be a Millionaire-Maker Stock?

    6:11 a.m. May 30, 2021

    - Motley Fool

  4. Top Holdings Of Dividend ETFs (Part 1: The Top 50 In May 2021)

    10:51 a.m. May 29, 2021

    - Seeking Alpha

  5. Stocks Resume Rally

    4:05 p.m. May 28, 2021

    - Seeking Alpha

  6. 7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

    10:07 a.m. May 26, 2021

    - InvestorPlace.com

  7. Can This Forgotten Coronavirus Stock Make You Rich?

    10:57 a.m. May 25, 2021

    - Motley Fool

  8. Poor Countries Ask Wealthy Ones to Do More to Stave Off Covid-19 Surge

    10:06 a.m. May 21, 2021

    - Gabriele Steinhauser

  9. Loading more headlines...
/news/pressrelease/company/us/gild

Press Releases on GILD

  1. Cellular Therapy (CT) Market Overview 2021 to 2026

    6:14 a.m. June 11, 2021

    - Market Insight Reports

  2. Dental Anesthetics Market Size, Share, Trends, Analysis and Forecast 2027

    11:35 a.m. June 10, 2021

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.